Companies: 10,795·Total market cap: $144.5T
CTI BioPharma Corp.

CTI BioPharma Corp.

CTICNASDAQHealthcare
$9.10
+$0.01(+0.06%)
Market Cap$1.2B
P/E Ratio
52W High$9.1
52W Low$4.01

CTI BioPharma Corp.(CTIC)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CTIC · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-122019-122018-12
Revenue
Revenue$53.95M$0.00M$0.00M$3.35M$26.29M
Cost of Revenue$3.51M$0.16M$4.20M$0.00M$0.88M
Gross Profit$50.43M($0.16M)($4.20M)$3.35M$25.41M
Gross Margin %(computed)93.49%100.00%96.66%
Operating Expenses
R&D Expenses$36.90M$39.14M$25.94M$24.11M$36.47M
G&A Expenses$0.00M$0.00M$17.63M$0.00M$0.00M
Total Operating Expenses$130.23M$95.33M$47.77M$43.26M$57.65M
Operating Income($79.80M)($95.33M)($47.77M)($40.71M)($32.90M)
Operating Margin %(computed)-147.91%-125.14%
Interest Income$1.68M$0.04M$0.20M$1.17M$1.22M
Interest Expense$13.14M$2.42M$1.03M$1.52M$1.73M
Income Before Tax($92.99M)($97.91M)($52.45M)($40.02M)($29.35M)
Income Tax Expense($1.95M)$1.73M$0.50M$2.29M$5.28M
Net Income($91.04M)($99.64M)($52.95M)($42.32M)($29.32M)
Net Margin %(computed)-168.76%-111.53%
Per Share & EBITDA
EPS (Basic)$-0.79$-1.11$-0.74$-0.73$-0.52
Wtd Avg Shares114.69M90.12M71.14M57.97M56.07M
EBITDA($79.85M)($95.33M)($51.22M)($37.42M)($32.90M)
EBITDA Margin %(computed)-148.02%-125.14%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解CTI BioPharma Corp.

关于CTI BioPharma Corp.(CTIC)损益表

CTI BioPharma Corp.(CTIC)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,CTIC实现营收$0.05B,毛利润$0.05B(毛利率93.49%),净利润($0.09B)(净利率-168.76%)。

常见问题

CTIC · 4 问

CTI BioPharma Corp.(CTIC)2022财年营收为$0.05B,同比up—%。

CTIC revenueCTIC salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09